Y-mAbs Therapeutics, Inc.
YMAB
$8.54
$0.0050.06%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -22.22M | -28.23M | -29.67M | -23.86M | -24.61M |
| Total Depreciation and Amortization | 347.00K | 447.00K | 535.00K | 594.00K | 641.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.55M | 15.26M | 17.07M | 13.26M | 13.06M |
| Change in Net Operating Assets | -8.47M | -6.62M | -3.65M | -11.87M | -1.64M |
| Cash from Operations | -17.80M | -19.15M | -15.71M | -21.88M | -12.55M |
| Capital Expenditure | -127.00K | -127.00K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -127.00K | -127.00K | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.41M | 3.84M | 4.31M | 3.43M | 2.45M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.41M | 3.84M | 4.31M | 3.43M | 2.45M |
| Foreign Exchange rate Adjustments | -2.00K | -1.00K | 0.00 | 6.00K | 4.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15.51M | -15.44M | -11.40M | -18.45M | -10.10M |